Find a Collaborator

Home › Partnerships & Collaborations › Find a Collaborator › On Your Cancer of Interest

Haematological

Dr Shruti BHATT

Haematological

The central focus of research is to identify treatment strategies and underlying mechanisms of therapy-resistant myeloid tumors by studying clonal evolutionary path and cell death mechanisms, particularly the mitochondrial pathway of apoptosis.

Prof Dario CAMPANA

Haematological

Research focus is on the development of innovative technologies to treat cancer with immune cells, and their translation into first-in human clinical trials.

Dr CHEONG Jit Kong

Haematological

Research focus is on uncovering and characterising novel signalling nodes of oncogenic RAS-driven human cancers to facilitate the development of tractable therapeutic modalities.

Prof CHNG Wee Joo

Haematological

Research focus is on blood cancers to understand how the disease develops and find better ways to treat them.

Dr Anand Devaprasath JEYASEKHARAN

Haematological

Clinical research focuses on combinatorial drug therapy trials in lymphoma, and methods for evaluating cancer phenotypes for personalized treatment choice. Biological research focuses on understanding the signalling pathways involved in activation of immune responses after chemotherapy.

Prof KOH Liang Piu

Haematological

Research focuses mainly on clinical Haematopoietic Stem Cell Transplantation in particular Nonmyeloablative Stem Cell Transplant, haploidentical donor transplant, Umbilical Cord Blood Transplantation in Haematological Malignancies. He also the leading primary investigators on clinical trials on Infectious Complications in Haematological / Haematopoietic Stem Cell Transplantation Recipients, studies on Graft vs. Host Disease prevention and treatment.

A/Prof NG Siok Bian

Haematological

Research focus is to identify and validate novel markers of prognostic and therapeutic importance in EBV-associated T- and NK-cell lymphomas and lymphoproliferative diseases, a group of aggressive tumours which are prevalent in Asia.

Dr OOI Gaik Ming, Melissa

Haematological

She is currently the leukaemia group lead in National University Cancer Institute of Singapore and is also heavily involved in myeloma, leukaemia and myelodysplasia clinical care and research. She is also interested in health service research and geriatric research.

Dr TAY Kah Ping, Andy

Haematological

The research focus of the Tay lab is tissue-specific drug delivery and immunotherapeutics against cancer.

Prof YEOH Eng Juh, Allen

Haematological

Research focus is on improving Acute Lymphoblastic Leukaemia treatment in children and adults by better prediction of each patient’s risk of relapse using highly sensitive biomarkers like RNA-Seq and MRD measurements. Prof Yeoh works on immune cell therapy especially CAR-T cell therapy for leukaemia with Prof Dario Campana in NUSMed.

Dr ZHOU Jianbiao

Haematological

Research focus is on the drug resistance mechanisms and aggressive phenotypes in hematologic malignancies, as well as the development predictive markers, novel therapeutic targets.

A/Prof YEOH Eng Juh, Allen

Haematological

Research focus is on improving Acute Lymphoblastic Leukaemia treatment in children and adults by better prediction of each patient’s risk of relapse using highly sensitive biomarkers like RNA-Seq and MRD measurements. A/Prof Yeoh works on immune cell therapy especially CAR-T cell therapy for leukaemia with Prof Dario Campana in NUSMed.

Secondary Members

A/Prof Michelle POON

Haematological

Research interest is in hematopoietic stem cell Transplantation and cellular therapy.

Prof Vinay TERGAONKAR

Haematological

My lab aims to understand fundamental mechanisms by which novel RNAs regulate carcinogenesis.

Dr CHEONG Jit Kong

Haematological

Research focus is on uncovering and characterising novel signalling nodes of oncogenic RAS-driven human cancers to facilitate the development of tractable therapeutic modalities.